A Study of Avastin (Bevacizumab) And Fotemustine in Patients With Recurrent Glioblastoma

NCT01474239 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

91

Enrollment

INDUSTRY

Sponsor class

Conditions

Glioblastoma Multiforme

Interventions

DRUG: bevacizumab [Avastin]
DRUG: fotemustine

Sponsor

Hoffmann-La Roche